Roles of lipocalin 2 and adiponectin in iron overload cardiomyopathy

Area of Science:

• Cardiovascular Medicine
• Hematology
• Biochemistry

Background:

• Thalassemia, a common genetic disorder, leads to iron overload from ineffective erythropoiesis, hemolysis, and transfusions.
• Iron overload cardiomyopathy is a severe complication and leading cause of mortality in thalassemia patients.
• Key mechanisms involve cellular iron mishandling, chronic inflammation, and oxidative stress.

Purpose of the Study:

• To investigate the roles of lipocalin 2 and adiponectin in iron overload cardiomyopathy.
• To provide a comprehensive overview of current research on these molecules in thalassemia.

Main Methods:

• Comprehensive review of in vitro and in vivo studies.
• Analysis of clinical studies in thalassemia patients.

Main Results:

• Lipocalin 2, an iron-transporting protein, and adiponectin, an anti-inflammatory adipokine, show potential roles in iron overload cardiomyopathy.
• Summarizes findings from experimental and clinical investigations.

Conclusions:

• Lipocalin 2 and adiponectin are emergent molecules requiring further investigation in iron overload cardiomyopathy.
• Understanding their impact is crucial for managing cardiac complications in thalassemia.